Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Modern antiematogenic therapy from 5-HT3 to NK-1 antagonists

Share :

Best of ASCO® Miami 2016

8 - 10 Jul 2016
Published: 25 Jul 2016
Views: 2889
Rating:
Save
Dr Sayeh Lavasani - Memorial Cancer Institute, Hollywood, Florida, USA

Dr Lavasani speaks with ecancertv at the Best of ASCO 2016 about limiting the risk of nausea as a result of chemotherapy.

She describes results from international teams, including adjuvant rolapitant and the impact of reduced dexamethasone exposure.

Related Videos

Addressing Breast Cancer Disparities in Africa
Dr Paul Chilwesa - Population Health & Health Systems Strengthening Roche...
Addressing Breast Cancer Disparities in Africa ( Dr Paul Chilwesa - Population Health & Health Systems Strengthening Roche, Basel, Switzerland )
6 Dec 2024
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Dr Elias Mai - Heidelberg University, Heidelberg, Germany
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM ( Dr Elias Mai - Heidelberg University, Heidelberg, Germany )
28 Oct 2024
Gaza's cancer patients: Navigating the dual struggle of illness and war
Dr Ru'a Rimawi - Dana-Farber Cancer Institute, Boston, United States of America
Gaza's cancer patients: Navigating the dual struggle of illness and war ( Dr Ru'a Rimawi - Dana-Farber Cancer Institute, Boston, United States of America )
24 Oct 2024
Genomic testing: Awareness and effective communication between healthcare...
Prof Richard Simcock and Antonella Cardone
Genomic testing: Awareness and effective communication between healthcare professionals and patients ( Prof Richard Simcock and Antonella Cardone )
22 Oct 2023
The Vietnam National Cancer Institute’s efforts in improving cancer care in...
Dr Thanh Huong Tran Thi - Director, Vietnam National Cancer Institute
The Vietnam National Cancer Institute’s efforts in improving cancer care in Vietnam ( Dr Thanh Huong Tran Thi - Director, Vietnam National Cancer Institute )
5 Sep 2023
The Southeast Asian Breast Cancer Symposium; background, aims and successes
Carolyn Taylor - Executive Director, Global Focus on Cancer
The Southeast Asian Breast Cancer Symposium; background, aims and successes ( Carolyn Taylor - Executive Director, Global Focus on Cancer )
5 Sep 2023
The current status of multiple myeloma diagnosis and treatment
Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina
The current status of multiple myeloma diagnosis and treatment ( Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina )
24 May 2023
The use of IORT at Universitätsmedizin Mannheim hospital
Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany
The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )
2 May 2023
Overview of the management of HER2-low breast cancer patients
Prof Hope Rugo - University of California San Francisco, San Francisco, USA
Overview of the management of HER2-low breast cancer patients ( Prof Hope Rugo - University of California San Francisco, San Francisco, USA )
3 Feb 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation